Acesso livre
Acesso livre

Destaques

Estudo de coorte | Uso de cannabis por longo prazo está associado com déficits cognitivos e menor volume do hipocampo na meia-idade.

14 Mar, 2022 | 13:58h

Long-Term Cannabis Use and Cognitive Reserves and Hippocampal Volume in Midlife – The American Journal of Psychiatry (link para o resumo – $ para o texto completo)

Comentário: Long-Term Cannabis Use Associated With Cognitive Deficits in Midlife – Psychiatric News Alert

Desfechos da qualidade de vida com tratamento invasivo vs. conservador da doença coronariana crônica no estudo ISCHEMIA.

14 Mar, 2022 | 13:55h

Comprehensive Quality of Life Outcomes with Invasive versus Conservative Management of Chronic Coronary Disease in ISCHEMIA – Circulation (link para o resumo – $ para o texto completo)

Artigos originais:

ISCHEMIA Trial: Health-Status Outcomes with Initial Invasive vs. Conservative Care in Stable Coronary Disease

ISCHEMIA Trial: Initial Invasive vs. Conservative Strategy for Stable Coronary Disease

ISCHEMIA Trial: Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease

ISCHEMIA Trial: Management of Coronary Disease in Patients with Advanced Kidney Disease

 

Comentário no Twitter

 

Abordagens práticas e baseadas em evidências para modificações nutricionais visando à redução da doença cardiovascular aterosclerótica.

14 Mar, 2022 | 13:53h

Practical, Evidence-Based Approaches to Nutritional Modifications to Reduce Atherosclerotic Cardiovascular Disease: An American Society For Preventive Cardiology Clinical Practice Statement – American Journal of Preventive Cardiology

Estudo randomizado | Metenamina hipurato (um tratamento preventivo não antibiótico) é não inferior a antibióticos profiláticos para tratar infecções recorrentes de trato urinário em mulheres.

11 Mar, 2022 | 15:19h

Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial – The BMJ

Comunicado de imprensa: Antiseptic drug as good as antibiotics for preventing recurrent urinary tract infections – BMJ Newsroom

Editorial: Methenamine hippurate for recurrent urinary tract infections – The BMJ

Comentários:

Trial supports antibiotic alternative for recurrent urinary infections – CIDRAP

Nonantibiotic Prophylaxis Noninferior for Recurrent UTI – HealthDay

 

Comentário no Twitter

 

Diretriz OMS | Uso de testes diagnósticos rápidos de detecção de antígeno do SARS-CoV-2 para o autoteste de COVID-19.

11 Mar, 2022 | 15:18h

Use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing – World Health Organization

Revisão sistemática | Corticosteroides inalatórios para tratamento da COVID-19.

11 Mar, 2022 | 15:16h

Inhaled corticosteroids for the treatment of COVID‐19 – Cochrane Library

Conteúdos relacionados:

[Preprint] M-A: Inhaled corticosteroids in COVID-19 outpatients.

PRINCIPLE RCT: Inhaled budesonide improves time to recovery from COVID-19 in people at high risk of complications in the community.

Position Paper: Recommendations for the use of topical inhalant budesonide in COVID-19.

RCT: Inhaled budesonide shortens recovery time in non-hospitalized patients with COVID-19

Phase 2 RCT: Inhaled budesonide shows promise for the treatment of early COVID-19

 

Comentário no Twitter (fio – clique para saber mais)

 

Estimativa do excesso de mortalidade decorrente da pandemia de COVID-19.

11 Mar, 2022 | 15:15h

Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21 – The Lancet

Comunicado de imprensa: Global death toll of COVID-19 pandemic may be more than three times higher than official records, estimates of excess deaths indicate – The Lancet

Comentários:

COVID’s true death toll: far higher than official records – Nature

Covid deaths probably three times higher than records say – BBC

Conteúdos relacionados:

Editorial: “Excess deaths” is the best metric for tracking the pandemic.

The pandemic’s true death toll: millions more than official counts.

We can be confident there have been far more than 5 million global Covid deaths – “Estimating ‘excess’ fatalities, a more robust analysis method, puts the pandemic’s grim toll between 10m and 19m people”.

Global Covid-19 deaths surpass five million.

Effects of the Covid-19 pandemic on life expectancy and premature mortality in 2020 – this time series analysis showed there were more than 28 million excess years of life lost in 2020 in 31 countries.

Under-reporting of deaths limits our understanding of true burden of covid-19.

Study shows COVID-19 has caused the biggest decrease in life expectancy since World War II.

Just how do deaths due to COVID-19 stack up?

Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset.

Exploring the gap between excess mortality and COVID-19 deaths in 67 countries.

Report: Three new estimates of India’s all-cause excess mortality during the COVID-19 Pandemic – pandemic death toll estimated to be between 3.4 million and 4.9 million excess deaths.

COVID-19 has caused 6.9 million deaths globally, more than double what official reports show

 

Comentário no Twitter

 

Outro estudo sugere que a 3ª dose de vacina é necessária para proteger as populações contra a variante Ômicron.

11 Mar, 2022 | 15:13h

Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study – The BMJ

Comunicado de imprensa: Third vaccine dose critical for protecting populations against omicron variant – BMJ Newsroom

 

Comentário no Twitter

 

2º aniversário da pandemia de COVID: 3 erros cometidos e 3 pontos a observar.

11 Mar, 2022 | 15:11h

COVID pandemic 2nd anniversary: 3 things we got wrong, and 3 things to watch out for – The Conversation

Estudo de coorte retrospectivo | Frequência e desfechos da adenopatia axilar detectada por ressonância magnética após vacinação contra COVID-19.

11 Mar, 2022 | 15:10h

Frequency and outcomes of MRI-detected axillary adenopathy following COVID-19 vaccination – European Radiology

Conteúdos relacionados:

Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care.

2 Case Series and Guidance | Lymphadenopathy in COVID-19 Vaccine Recipients

Axillary lymphadenopathy at the time of COVID-19 vaccination: ten recommendations from the European Society of Breast Imaging.

Covid-19: Schedule breast screening before vaccine or 4 to 6 weeks after to avoid false positives, says guidance

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.